1.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 2010ESO_FU, NCT01402180
|
|
2.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 21 to 70 Sponsor: Other Protocol IDs: IHN01, NCT00957086
|
|
3.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 70 Sponsor: Pharmaceutical / Industry Protocol IDs: BT-CT-001, NCT01074021
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 21 to 70 Sponsor: Other Protocol IDs: IB/NCCS-01, NCT00702481
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: BT-CRC-T, NCT00972465
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Pharmaceutical / Industry Protocol IDs: BT-IST-NSCLC-010, NCT00983047
|
|
7.
|
Phase: Phase II Type: Treatment Status: Active Age: 3 to 18 Sponsor: Other Protocol IDs: EF090, NCT01145170
|
|
8.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: CH-GI-010, NCT01180166
|
|
9.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Pharmaceutical / Industry Protocol IDs: BT-ESO-1001, NCT01232374
|
|
10.
|
Phase: Phase II Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: EF 110, NCT01301612
|
|
11.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: N+TP-AEC3, NCT01336049
|
|
12.
|
Phase: Phase II Type: Treatment Status: Approved-not yet active Age: 18 to 70 Sponsor: Other Protocol IDs: EF 118, NCT01345084
|
|
13.
|
Phase: Phase II Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 11-044, NCT01382745
|
|
14.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: BT-IST-SCCHN-008, NCT01425736
|
|
15.
|
Phase: Phase II Type: Treatment Status: Active Age: 20 and over Sponsor: Other Protocol IDs: 4-2011-0662, NCT01498562
|
|
16.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: N+FOLFIRI-AEC-4, NCT01486992
|
|
17.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: BT-IST-SCCHN-036, NCT01516996
|
|
18.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: PF-N-UMNPC, NCT01616849
|
|
19.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 to 75 Sponsor: Pharmaceutical / Industry Protocol IDs: BT-ESO-T-0901, NCT00950417
|
|
20.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 to 65 Sponsor: Pharmaceutical / Industry Protocol IDs: BT-NSCLC-T-0902, NCT00985998
|
|
21.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: OSAG101-PCS07, NCT00561990
|
|
22.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: BT-IST-NSCLC-053, NCT01393080
|